(Q48346206)

10 February 2018

title

EEG in the FEAB model: measurement of electroencephalographical burst suppression and seizure liability in safety pharmacology (English)

1 reference

10 February 2018

main subject

electroencephalography

1 reference

1 reference

1 reference

Wilhelmus Drinkenburg

5

1 reference

10 February 2018

author name string

H J van der Linde

1

1 reference

10 February 2018

B Van Deuren

2

1 reference

10 February 2018

Y Somers

3

1 reference

10 February 2018

A Teisman

4

1 reference

10 February 2018

D J Gallacher

6

1 reference

10 February 2018

publication date

22 June 2010

1 reference

10 February 2018

Journal of Pharmacological and Toxicological Methods

published in

1 reference

10 February 2018

volume

63

1 reference

10 February 2018

issue

1

1 reference

10 February 2018

page(s)

96-101

1 reference

10 February 2018

Electroencephalography in dogs with epilepsy: similarities between human and canine findings

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.06.002

Respiratory physiology of seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.06.002

Cardiovascular and neurological effects of laudanosine. Studies in mice and rats, and in conscious and anaesthetized dogs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.06.002

Burst suppression or isoelectric encephalogram for cerebral protection: evidence from metabolic suppression studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.06.002

The use of the dog electroencephalogram (EEG) in safety pharmacology to evaluate proconvulsant risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.06.002

Approaches to seizure risk assessment in preclinical drug discovery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.06.002

Effects of propofol or etomidate on QT interval during electroconvulsive therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.06.002

Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.06.002

Clinical and electroencephalographical classification of epileptic seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.06.002

In nonconvulsive status epilepticus (NCSE), treat to burst-suppression: pro and con.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.06.002

The Narcotrend--a new EEG monitor designed to measure the depth of anaesthesia. A comparison with bispectral index monitoring during propofol-remifentanil-anaesthesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.06.002

7 January 2021

The Narcotrend monitor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.06.002

Timed pentylenetetrazol infusion test: a comparative analysis with s.c.PTZ and MES models of anticonvulsant screening in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.06.002

Cardiac effects of seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.06.002

Intracranial pressure during induction of anaesthesia and tracheal intubation with etomidate-induced EEG burst suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.06.002

EEG power spectrum analysis for monitoring depth of anaesthesia during experimental surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.06.002

A timed intravenous pentylenetetrazol infusion seizure model for quantitating the anticonvulsant effect of valproic acid in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.06.002

New perspectives in CNS safety pharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.06.002

Effects of High-dose Fentanyl Anesthesia on the Electroencephalogram

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.06.002

Anesthetic effects on electrophysiologic recordings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.06.002

Cortical and thalamic cellular correlates of electroencephalographic burst-suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.06.002

Bupropion-induced convulsions: preclinical evaluation of antiepileptic drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.06.002

The fentanyl/etomidate-anaesthetised beagle (FEAB) dog: a versatile in vivo model in cardiovascular safety research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.06.002

Pentobarbital and EEG burst suppression in treatment of status epilepticus refractory to benzodiazepines and phenytoin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.06.002

I.v. anaesthesia and EEG burst suppression in rats: bolus injections and closed-loop infusions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.06.002

Presence of electroencephalogram burst suppression in sedated, critically ill patients is associated with increased mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.06.002

Heart rate changes and ECG abnormalities during epileptic seizures: prevalence and definition of an objective clinical sign

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.06.002

10.1016/J.VASCN.2010.06.002

7 January 2021

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018